Treatment of multiple sclerosis with a synthetic polypeptide: preliminary results.
作者信息
Bornstein M B, Miller A E, Teitelbaum D, Arnon R, Sela M
出版信息
Trans Am Neurol Assoc. 1980;105:348-50.
PMID:6758285
Abstract
摘要
相似文献
1
Treatment of multiple sclerosis with a synthetic polypeptide: preliminary results.用合成多肽治疗多发性硬化症：初步结果。
Trans Am Neurol Assoc. 1980;105:348-50.
2
Multiple sclerosis: trial of a synthetic polypeptide.多发性硬化症：一种合成多肽的试验
Ann Neurol. 1982 Mar;11(3):317-9. doi: 10.1002/ana.410110314.
3
A multiple sclerosis therapy?一种多发性硬化症疗法？
Nature. 1987;328(6132):664-5. doi: 10.1038/328664a0.
4
Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.多发性硬化症治疗的扩展临床试验：共聚肽1（COP-1）治疗新药研究（IND）项目。
Ann Neurol. 1994 Jul;36(1):114-5. doi: 10.1002/ana.410360123.
5
Cop 1 therapy for multiple sclerosis.用于治疗多发性硬化症的Cop 1疗法。
N Engl J Med. 1987 Aug 13;317(7):442-4. doi: 10.1056/NEJM198708133170708.
6
The use of glatiramer acetate in the treatment of multiple sclerosis.醋酸格拉替雷在多发性硬化症治疗中的应用。
Adv Neurol. 2006;98:273-92.
7
8
[Multiple sclerosis: immunomodulators brake the appearance of "black holes"].[多发性硬化症：免疫调节剂抑制“黑洞”的出现]
MMW Fortschr Med. 2003 May 26;145 Suppl 2:110.
9
Translating new insights into treatment optimisation in multiple sclerosis.将新见解转化为多发性硬化症治疗优化方案。
J Neurol Sci. 2009 Feb 1;277 Suppl 1:S1-2. doi: 10.1016/S0022-510X(09)70002-4.
10
Combination therapy for treatment of multiple sclerosis.用于治疗多发性硬化症的联合疗法。
Ann Neurol. 1998 Jul;44(1):7-9. doi: 10.1002/ana.410440106.
引用本文的文献
1
Multiple sclerosis. Current concepts in management.多发性硬化症。管理方面的当前概念。
Drugs. 1985 Jan;29(1):88-95. doi: 10.2165/00003495-198529010-00004.
Zotero 插件